TP53 and glioblastoma: Among all hotspot sequence alterations identified in GBM, 7.0% were sub-clonal and varied by gene: 32.1% of EGFR, 6.5% of PTEN and 3.7% of TP53 hotspot mutations were sub-clonal (Figure 1B and Supplementary Table S10).